Ruth Brauer1,2, Maria Herrero-Zazo3, David J Barlow3, Fiona Gaughran1,4, David Taylor1,3,4, Louise M Howard1,4. 1. 1 Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. 2. 2 Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK. 3. 3 Department of Pharmacy and Forensic Science, Institute of Pharmaceutical Science, King's College London, London, UK. 4. 4 South London and Maudsley NHS Foundation Trust, London, UK.
Abstract
BACKGROUND: Minocycline has neurological anti-inflammatory properties and has been hypothesised to have antipsychotic effects. AIM: The aim of this study was to investigate, using routinely collected United Kingdom primary health care data, whether adolescent men and women are more or less likely to receive an urgent psychiatric referral during treatment for acne with minocycline compared with periods of non-treatment. METHOD: A self-controlled case series using United Kingdom Clinical Practice Research Datalink to calculate the incidence rate ratio of urgent psychiatric referrals for individuals, comparing periods during which minocycline was prescribed with unexposed periods, adjusted for age. RESULTS: We found 167 individuals who were at the time exposed to minocycline for a mean of 99 days and who received an urgent psychiatric referral. There was no difference in psychiatric referral risk during periods of exposure compared with periods of non-exposure: incidence rate ratio first 6 weeks of exposure 1.96, 95% confidence interval 0.82-4.71, p=0.132; incidence rate ratio remaining exposure period=1.97, 95% confidence interval 0.86-4.47, p=0.107. CONCLUSIONS: We found no evidence in support of a protective effect of minocycline against severe psychiatric symptoms in adolescence.
BACKGROUND: Minocycline has neurological anti-inflammatory properties and has been hypothesised to have antipsychotic effects. AIM: The aim of this study was to investigate, using routinely collected United Kingdom primary health care data, whether adolescent men and women are more or less likely to receive an urgent psychiatric referral during treatment for acne with minocycline compared with periods of non-treatment. METHOD: A self-controlled case series using United Kingdom Clinical Practice Research Datalink to calculate the incidence rate ratio of urgent psychiatric referrals for individuals, comparing periods during which minocycline was prescribed with unexposed periods, adjusted for age. RESULTS: We found 167 individuals who were at the time exposed to minocycline for a mean of 99 days and who received an urgent psychiatric referral. There was no difference in psychiatric referral risk during periods of exposure compared with periods of non-exposure: incidence rate ratio first 6 weeks of exposure 1.96, 95% confidence interval 0.82-4.71, p=0.132; incidence rate ratio remaining exposure period=1.97, 95% confidence interval 0.86-4.47, p=0.107. CONCLUSIONS: We found no evidence in support of a protective effect of minocycline against severe psychiatric symptoms in adolescence.
Authors: Jia Li; Meng Zheng; Olga Shimoni; William A Banks; Ashley I Bush; Jennifer R Gamble; Bingyang Shi Journal: Adv Sci (Weinh) Date: 2021-06-03 Impact factor: 16.806